28-30 January 2019
Paris, France

The microbiome community is looking to partner with you.

Drug developers are actively seeking external expertise in order to successfully overcome key biological and commercial challenges to ensure their microbiome therapies are true innovations. While the promise of the microbiome is huge, this novel class of therapeutics is going to take a unique approach to designing high throughput screening experiments, formulating computational and mouse models, industrially scaling-up drug manufacturing and designing clinical trials.

Who will you meet? 

We want to hear from you. Tell us how we can help reach your goals and overcome your challenges.